For the quarter ending 2025-09-30, BCYC has $763,954K in assets. $145,475K in debts. $648,325K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 648,325 | 721,451 | ||
| Prepaid expenses and other current assets | 23,231 | 22,058 | ||
| Research and development incentives receivable | 67,263 | 60,753 | ||
| Total current assets | 738,819 | 804,262 | ||
| Property and equipment, net | 6,861 | 8,307 | ||
| Operating lease right-of-use assets | 4,562 | 5,806 | ||
| Other assets | 13,712 | 13,809 | ||
| Total assets | 763,954 | 832,184 | ||
| Accounts payable | 12,653 | 18,263 | ||
| Accrued expenses and other current liabilities | 44,368 | 44,538 | ||
| Deferred revenue, current portion | 12,261 | 14,621 | ||
| Total current liabilities | 69,282 | 77,422 | ||
| Operating lease liabilities, net of current portion | 981 | 1,765 | ||
| Deferred revenue, net of current portion | 74,119 | 82,943 | ||
| Other longterm liabilities | 1,093 | 1,139 | ||
| Total liabilities | 145,475 | 163,269 | ||
| Ordinary shares, including non-voting ordinary shares, 0.01 nominal value 159,690,229 and 155,876,645 shares authorized on september 30, 2025 and december 31, 2024, respectively 69,306,511 and 69,061,418 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 894 | 893 | ||
| Additional paid-in capital | 1,500,653 | 1,491,882 | ||
| Accumulated other comprehensive (loss) income | -3,471 | -3,363 | ||
| Accumulated deficit | -879,597 | -820,497 | ||
| Total shareholders' equity | 618,479 | 668,915 | ||
| Total liabilities and shareholders' equity | 763,954 | 832,184 | ||
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)